Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
DHDanaher Corporation logo

Danaher Corporation (DHR)

New York Stock Exchange · Currency in USD
$230.50 ▲ +0.75 (+0.33%)
At close: Oct 23, 4:01 PM ET. Market closed.
$230.65 ▲ +0.15 (+0.07%)
After hours: Oct 23, 7:38 PM ET

Summary

Previous Close
$229.75
Open
$229.17
Day's Range
$225.61 – $230.63
52 Week Range
$160.93 – $242.80
Volume
3,935,866
Avg. Volume
4,727,671
Market Cap
$162.04B
Beta (5Y Monthly)
0.80
PE Ratio (TTM)
37.66
EPS (TTM)
$6.15
Earnings Date
Jan 27, 2027
Forward Dividend & Yield
$1.60 (0.69%)
Ex-Dividend Date
Sep 30, 2026
1y Target Est
$238.77

Profile: Danaher Corporation

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
59,000
CEO
Julie Sawyer Montgomery

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development.

Earnings

Next report: Wed, Jan 27, 2027
EPS estimate $2.50 · Revenue est. $7.50B
DateEst.Actual
Oct 21, 2026$1.92$2.11Beat
Jul 21, 2026$1.85$1.94Beat
Apr 21, 2026$1.94$2.06Beat
Jan 28, 2026$2.16$2.23Beat
Oct 21, 2025$1.72$1.89Beat
Jul 22, 2025$1.64$1.80Beat

Analyst view

Consensus price target
$238.77 ▲ +3.6%
Range $195.00 – $275.00
Rating: Buy
Buy 72% · Hold 26% · Sell 2%

Get free alerts on DHR and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.